申请人:Adir et Compagnie
公开号:US06063804A1
公开(公告)日:2000-05-16
Compounds of formula (I): ##STR1## wherein: R represents hydrogen, alkyl, optionally-substituted amino, or linear or branched (C.sub.1 -C.sub.6)-acyl, R.sub.1 and R.sub.2, which may be identical or different, each represents independently of the other aryl, heteroaryl, or (C.sub.5 -C.sub.7)-cycloalkyl, or one of those groups optionally substituted, A, together with the atoms in common with the pyrrole, represents saturated or unsaturated, monocyclic or bicyclic (C.sub.3 -C.sub.12)-cycloalkyl, or a saturated heterocycle having 5 to 7 ring members and containing one or two nitrogen, or 7-oxabicyclo[2.2.1]heptane, or one of those groups optionally substituted, their isomers, and also addition salts thereof with a pharmaceutically-acceptable acid or base, pharmaceutical compositions thereof, and use thereof as medicaments.
化合物的公式(I):##STR1## 其中: R代表氢、烷基、可选取代的氨基或线性或支链(C.sub.1-C.sub.6)-酰基,R.sub.1和R.sub.2,可以相同也可以不同,分别独立地表示芳基、杂环芳基或(C.sub.5-C.sub.7)-环烷基,或这些基团中的一个可选取代,A与吡咯中共有的原子一起表示饱和或不饱和、单环或双环(C.sub.3-C.sub.12)-环烷基,或含有5到7个环成员并含有一或两个氮的饱和杂环,或7-氧代双环[2.2.1]庚烷,或这些基团中的一个可选取代,它们的异构体以及与药学上可接受的酸或碱的加合物,其制备的制药组合物,以及其作为药物的用途。